Topicals represent 5.1% of total prescriptions and 14% of total drug cost, and are being prescribed as an alternative to some oral medications. Within this class, cost drivers including prescription (Rx) and private label topical analgesics (PLTAs) are associated with limited clinical efficacy and exorbitant pricing that often eliminates them as a favorable first-line therapy option. These and other challenges call for careful oversight that includes identification, clinical review and intervention, and/or recommendation of therapeutic alternatives where appropriate to help control inappropriate utilization and spend. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Overview of California Closed Formulary Draft Rules
DOWNERS GROVE, Ill.
Workers' Comp
Article
Focusing on a Physical Work Injury Could Mean Missing a Mental Health Challenge
When an injury occurs employees place trust in their employer to provide reliable claim professionals, case managers, and providers to shape their
Elevate the Narrative
In the News
Enlyte’s Apricus Physical Medicine: A Game-Changer in Workers’ Comp or Just Another Competitor?
WorkcompWire
In the News
Enlyte Launches Apricus Physical Medicine Solution
Mitchell
News Release
Mitchell Technology to Power New Virtual Estimating Service from Collective
The program’s U.S.
Workers' Comp
Article
Honoring Those Who Drive Injured Employees’ Return to Work
National Case Management Week is a time to thank those who advocate for injured and disabled employeesReturn to work is a term wi